10.1016/0140-6736(91)90074-Y [DOI] [PubMed] [Google Scholar] 32.Nocentini A, Bonardi A, Pratesi S, Gratteri P, Dani C, Supuran ST
Clinical effects of the self-administered subcutaneous complement inhibitor zilucoplan in patients with moderate to severe generalized myasthenia gravis: results of a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
Supernatant from uninfected cells was used as a negative control and from cells lysed with 1% triton X-100 (final concentration) was a positive control
This makes them highly sought-after in advanced skincare routines
Contrary, the colon-colon anastomosis and adjacent colon in animals treated with the pentadecapeptide BPC 157 sustained markedly higher infunded volume without leaking